- Home
- NOTE vs RCEL Comparison
NOTE vs RCEL Comparison
Compare NOTE & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- RCEL
- Stock Information
- Founded
- NOTE 2013
- RCEL 2020
- Country
- NOTE United States
- RCEL United States
- Employees
- NOTE N/A
- RCEL N/A
- Industry
- NOTE EDP Services
- RCEL Medical/Dental Instruments
- Sector
- NOTE Technology
- RCEL Health Care
- Exchange
- NOTE Nasdaq
- RCEL Nasdaq
- Market Cap
- NOTE 184.1M
- RCEL 274.7M
- IPO Year
- NOTE N/A
- RCEL N/A
- Fundamental
- Price
- NOTE $1.16
- RCEL $10.47
- Analyst Decision
- NOTE Buy
- RCEL Hold
- Analyst Count
- NOTE 6
- RCEL 3
- Target Price
- NOTE $3.31
- RCEL $15.00
- AVG Volume (30 Days)
- NOTE 328.9K
- RCEL 89.6K
- Earning Date
- NOTE 11-12-2024
- RCEL 11-07-2024
- Dividend Yield
- NOTE N/A
- RCEL N/A
- EPS Growth
- NOTE N/A
- RCEL N/A
- EPS
- NOTE N/A
- RCEL N/A
- Revenue
- NOTE $129,632,000.00
- RCEL $54,139,000.00
- Revenue This Year
- NOTE N/A
- RCEL $40.31
- Revenue Next Year
- NOTE $8.23
- RCEL $45.42
- P/E Ratio
- NOTE N/A
- RCEL N/A
- Revenue Growth
- NOTE 3.80
- RCEL 32.53
- 52 Week Low
- NOTE $0.65
- RCEL $7.51
- 52 Week High
- NOTE $2.27
- RCEL $18.93
- Technical
- Relative Strength Index (RSI)
- NOTE 41.76
- RCEL 53.73
- Support Level
- NOTE $1.11
- RCEL $9.74
- Resistance Level
- NOTE $1.23
- RCEL $10.90
- Average True Range (ATR)
- NOTE 0.06
- RCEL 0.46
- MACD
- NOTE 0.00
- RCEL -0.05
- Stochastic Oscillator
- NOTE 23.33
- RCEL 53.28
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of global policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With expert analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.